SCHEMBL7155398

SCHEMBL7155398

CCCNc1cc(C(=O)NC(C=O)C(C)(C)C)cc(C(F)(F)F)c1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 8/20 0.50
CYP1A2 P05177 2/20 0.50
TAS1R3 Q7RTX0 2/20 0.41
TAS1R1 Q7RTX1 2/20 0.41
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
RHOC P08134 1/20 0.37
RHOA P61586 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CCR2 P41597 2/20 0.37
NNMT P40261 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
BCHE P06276 1/20 0.35
TACR1 P25103 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7107168 0.92 TRPA1 (0.45) TRPA1CYP1A2TAS1R3TAS1R1RHOC
SCHEMBL7113950 0.84 TRPA1 (0.48) TRPA1CYP1A2RHOCRHOANPSR1
SCHEMBL7112432 0.82 P2RX1 (0.40) ALDH1A1NPSR1NNMTHDAC3BCHE
SCHEMBL7107910 0.79 NPSR1 (0.41) TAS1R3TAS1R1RHOCRHOANPSR1
SCHEMBL5120346 0.76 TRPA1 (0.63) TRPA1CYP1A2ALDH1A1POLB
SCHEMBL7154000 0.71 L3MBTL1 (0.42) CYP1A2TAS1R3TAS1R1ALDH1A1NPSR1
SCHEMBL6231746 0.70 TRPA1 (0.56) TRPA1CYP1A2ALDH1A1POLB
SCHEMBL5119105 0.68 TRPA1 (0.53) TRPA1CYP1A2ALDH1A1POLBRHOC
SCHEMBL13753102 0.68 ALDH1A1 (0.72) TRPA1CYP1A2ALDH1A1POLBRHOC
SCHEMBL7112858 0.66 CCR2 (0.44) ALDH1A1CCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1351924-A2 DIAMINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Bristol-Myers Squibb Pharma Company (US) 2003-10-15 EP claimed
WO-2002050019-A2 DIAMINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB PHARMA CO. (US) 2002-06-27 WO claimed